Skip to main content
Market intelligence
EMBCHealthcare

Embecta Corp insider activity

In the last 90 days, 4 corporate insiders purchased $557,945 of stock on the open market.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
3
90-day purchase value
$557,945
Corporate buyers
4
Latest transaction
Aug 12, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Aug 12, 2026Devdatt KurdikarPresident and CEOOpen Market Purchase30,000$4.70$140,937
Aug 12, 2026Jacob ElguiczeSVP and CFOOpen Market Purchase20,000$4.67$93,360
Aug 12, 2026Jeffrey Z MannPres, Pharm Svc&Prod Mgmt, CLOOpen Market Purchase20,000$4.99$99,800